Collplant Biotechnologies LT
13F holders, Q2 2026 (June 30)1holders
0new positions
0sold out
$0.35avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Collplant Biotechnologies LT in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holder was Parallel Advisors, LLC ($25).
- Company
- Collplant Biotechnologies LT
- CUSIP
- 19516R107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Parallel Advisors, LLC | 0.00% | No change | 71 | $25 |
"% of holder's portfolio" is COLLPLANT BIOTECHNOLOGIES LT's weight in each manager's 13F, not the share of Collplant Biotechnologies LT the manager owns.